The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS

Chen Hung Ting, Han Ning Huang, Tsui Chin Huang, Chang Jer Wu, Jyh Yih Chen

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Pardaxin is a cationic antimicrobial peptide derived from Red Sea Moses sole. Previous studies have shown that pardaxin selectively triggers the death of cancer cells, initiating the development of a pardaxin-based cancer vaccine; however, the underlying mechanism by which pardaxin kills cancer cells has not yet been elucidated. Here, we demonstrate that this mechanism involves endoplasmic reticulum (ER) targeting and c-FOS induction. Transcriptiome analysis of pardaxin-treated HT-1080 cells revealed induction of the gene encoding c-FOS, an AP-1 transcription factor. Pardaxin mediates cell death by activating c-FOS, but not other AP-1 transcription factors. Overexpression of c-FOS caused a dramatic increase in cell death, while knockdown of c-FOS induced pardaxin resistance; such effects were observed in both an invitro cell model and an invivo xenograft tumor model. Treatment with pardaxin also increased the level of calcium, and blockage of cellular calcium signaling disrupted pardaxin-induced cell death. Immunocytochemistry was used to demonstrate targeting of pardaxin to the endoplasmic reticulum, but not to the Golgi apparatus or mitochondria. Importantly, pardaxin treatment or c-FOS overexpression induced cell death in diverse cancer cell lines, indicating that pardaxin and c-FOS may possess therapeutic potential for use in cancer treatment.

Original languageEnglish
Pages (from-to)3627-3640
Number of pages14
JournalBiomaterials
Volume35
Issue number11
DOIs
Publication statusPublished - Apr 2014

Fingerprint

Antimicrobial Cationic Peptides
Cell death
Endoplasmic Reticulum
Peptides
Transcription factors
Cells
Calcium
Cell Death
Mitochondria
Gene encoding
Oncology
Vaccines
Tumors
Transcription Factor AP-1
Neoplasms
pardaxin
Indian Ocean
Cancer Vaccines
Calcium Signaling
Golgi Apparatus

Keywords

  • C-FOS
  • Calcium
  • Cationic antimicrobial peptide
  • Endoplasmic reticulum
  • Pardaxin

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS. / Ting, Chen Hung; Huang, Han Ning; Huang, Tsui Chin; Wu, Chang Jer; Chen, Jyh Yih.

In: Biomaterials, Vol. 35, No. 11, 04.2014, p. 3627-3640.

Research output: Contribution to journalArticle

Ting, Chen Hung ; Huang, Han Ning ; Huang, Tsui Chin ; Wu, Chang Jer ; Chen, Jyh Yih. / The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS. In: Biomaterials. 2014 ; Vol. 35, No. 11. pp. 3627-3640.
@article{86fda73178da492a94669c0dc7da0aa0,
title = "The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS",
abstract = "Pardaxin is a cationic antimicrobial peptide derived from Red Sea Moses sole. Previous studies have shown that pardaxin selectively triggers the death of cancer cells, initiating the development of a pardaxin-based cancer vaccine; however, the underlying mechanism by which pardaxin kills cancer cells has not yet been elucidated. Here, we demonstrate that this mechanism involves endoplasmic reticulum (ER) targeting and c-FOS induction. Transcriptiome analysis of pardaxin-treated HT-1080 cells revealed induction of the gene encoding c-FOS, an AP-1 transcription factor. Pardaxin mediates cell death by activating c-FOS, but not other AP-1 transcription factors. Overexpression of c-FOS caused a dramatic increase in cell death, while knockdown of c-FOS induced pardaxin resistance; such effects were observed in both an invitro cell model and an invivo xenograft tumor model. Treatment with pardaxin also increased the level of calcium, and blockage of cellular calcium signaling disrupted pardaxin-induced cell death. Immunocytochemistry was used to demonstrate targeting of pardaxin to the endoplasmic reticulum, but not to the Golgi apparatus or mitochondria. Importantly, pardaxin treatment or c-FOS overexpression induced cell death in diverse cancer cell lines, indicating that pardaxin and c-FOS may possess therapeutic potential for use in cancer treatment.",
keywords = "C-FOS, Calcium, Cationic antimicrobial peptide, Endoplasmic reticulum, Pardaxin",
author = "Ting, {Chen Hung} and Huang, {Han Ning} and Huang, {Tsui Chin} and Wu, {Chang Jer} and Chen, {Jyh Yih}",
year = "2014",
month = "4",
doi = "10.1016/j.biomaterials.2014.01.032",
language = "English",
volume = "35",
pages = "3627--3640",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier Science Ltd",
number = "11",

}

TY - JOUR

T1 - The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS

AU - Ting, Chen Hung

AU - Huang, Han Ning

AU - Huang, Tsui Chin

AU - Wu, Chang Jer

AU - Chen, Jyh Yih

PY - 2014/4

Y1 - 2014/4

N2 - Pardaxin is a cationic antimicrobial peptide derived from Red Sea Moses sole. Previous studies have shown that pardaxin selectively triggers the death of cancer cells, initiating the development of a pardaxin-based cancer vaccine; however, the underlying mechanism by which pardaxin kills cancer cells has not yet been elucidated. Here, we demonstrate that this mechanism involves endoplasmic reticulum (ER) targeting and c-FOS induction. Transcriptiome analysis of pardaxin-treated HT-1080 cells revealed induction of the gene encoding c-FOS, an AP-1 transcription factor. Pardaxin mediates cell death by activating c-FOS, but not other AP-1 transcription factors. Overexpression of c-FOS caused a dramatic increase in cell death, while knockdown of c-FOS induced pardaxin resistance; such effects were observed in both an invitro cell model and an invivo xenograft tumor model. Treatment with pardaxin also increased the level of calcium, and blockage of cellular calcium signaling disrupted pardaxin-induced cell death. Immunocytochemistry was used to demonstrate targeting of pardaxin to the endoplasmic reticulum, but not to the Golgi apparatus or mitochondria. Importantly, pardaxin treatment or c-FOS overexpression induced cell death in diverse cancer cell lines, indicating that pardaxin and c-FOS may possess therapeutic potential for use in cancer treatment.

AB - Pardaxin is a cationic antimicrobial peptide derived from Red Sea Moses sole. Previous studies have shown that pardaxin selectively triggers the death of cancer cells, initiating the development of a pardaxin-based cancer vaccine; however, the underlying mechanism by which pardaxin kills cancer cells has not yet been elucidated. Here, we demonstrate that this mechanism involves endoplasmic reticulum (ER) targeting and c-FOS induction. Transcriptiome analysis of pardaxin-treated HT-1080 cells revealed induction of the gene encoding c-FOS, an AP-1 transcription factor. Pardaxin mediates cell death by activating c-FOS, but not other AP-1 transcription factors. Overexpression of c-FOS caused a dramatic increase in cell death, while knockdown of c-FOS induced pardaxin resistance; such effects were observed in both an invitro cell model and an invivo xenograft tumor model. Treatment with pardaxin also increased the level of calcium, and blockage of cellular calcium signaling disrupted pardaxin-induced cell death. Immunocytochemistry was used to demonstrate targeting of pardaxin to the endoplasmic reticulum, but not to the Golgi apparatus or mitochondria. Importantly, pardaxin treatment or c-FOS overexpression induced cell death in diverse cancer cell lines, indicating that pardaxin and c-FOS may possess therapeutic potential for use in cancer treatment.

KW - C-FOS

KW - Calcium

KW - Cationic antimicrobial peptide

KW - Endoplasmic reticulum

KW - Pardaxin

UR - http://www.scopus.com/inward/record.url?scp=84894934931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894934931&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2014.01.032

DO - 10.1016/j.biomaterials.2014.01.032

M3 - Article

VL - 35

SP - 3627

EP - 3640

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 11

ER -